Role of hyperphosphatemia-mediated vascular calcification in cardiovascular outcomes and its management: a review

被引:7
作者
Latif, Faisal [1 ,2 ]
Khalid, Muhammad Masood [3 ]
Khan, Fahad [1 ]
Omar, Zainab [4 ]
Ali, Fazal Akbar [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Sect, Oklahoma City, OK 73104 USA
[3] Dow Med Coll, Karachi, Pakistan
[4] King Edward Med Coll, Lahore, Pakistan
关键词
coronary artery disease; hyperphosphatemia; vascular calcification; CHRONIC KIDNEY-DISEASE; CALCIUM-SENSING RECEPTOR; STAGE RENAL-DISEASE; CORONARY-ARTERY CALCIFICATION; FREE PHOSPHATE BINDER; ALL-CAUSE MORTALITY; EXTRACELLULAR CALCIUM; SERUM PHOSPHORUS; CARDIAC CALCIFICATION; AORTIC CALCIFICATION;
D O I
10.2459/JCM.0b013e32835ec53d
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular diseases are the leading cause of death in patients with advanced renal disease. Although atherosclerosis is the major contributor, vascular calcification also plays an important role in progression of coronary as well as peripheral arterial disease in these patients. A large body of evidence suggests that hyperphosphatemia is the major contributor in progressive vascular calcification. We examine this large body of evidence with respect to the role of hyperphosphatemia in inducing vascular calcification and how, as a result, this possibly impacts an increase in adverse cardiovascular events. We also review various options as to how treating hyperphosphatemia might effect a decrease in cardiovascular morbidity and mortality.
引用
收藏
页码:410 / 415
页数:6
相关论文
共 79 条
[1]   The role of vitamin D in left ventricular hypertrophy and cardiac function [J].
Achinger, SG ;
Ayus, JC .
KIDNEY INTERNATIONAL, 2005, 67 :S37-S42
[2]   A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients [J].
Adragao, T ;
Pires, A ;
Lucas, C ;
Birne, R ;
Magalhaes, L ;
Gonçalves, M ;
Negrao, AP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (06) :1480-1488
[3]  
[Anonymous], 2000, Am J Kidney Dis, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517
[4]   Regulation of Phosphate Homeostasis by PTH, Vitamin D, and FGF23 [J].
Bergwitz, Clemens ;
Jueppner, Harald .
ANNUAL REVIEW OF MEDICINE, 2010, 61 :91-104
[5]   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942
[6]   Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease [J].
Blacher, J ;
Pannier, B ;
Guerin, AP ;
Marchais, SJ ;
Safar, ME ;
London, GM .
HYPERTENSION, 1998, 32 (03) :570-574
[7]   A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients [J].
Bleyer, AJ ;
Burke, SK ;
Dillon, M ;
Garrett, B ;
Kant, KS ;
Lynch, D ;
Rahman, SN ;
Schoenfeld, P ;
Teitelbaum, I ;
Zeig, S ;
Slatopolsky, E .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (04) :694-701
[8]   Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management [J].
Block, GA ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1226-1237
[9]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[10]   Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis [J].
Block, GA ;
Spiegel, DM ;
Ehrlich, J ;
Mehta, R ;
Lindbergh, J ;
Dreisbach, A ;
Raggi, P .
KIDNEY INTERNATIONAL, 2005, 68 (04) :1815-1824